Raymond M. Lahti
Chairs the Board. Manages the agenda; does not vote on matters where management has a direct financial interest.
Board of Directors · 9 seats
The Board of the operator. Distinct from the Council.
The Board governs the operating company — the C-corp, its capitalization, its officers, its filings. The Trust Council governs the chain and the privacy guarantees. The two bodies are deliberately separate so that no investor majority can rewrite the chain, and no Council majority can fire an officer. Today the Board has two seated directors (the founders); the seven other seats listed below are planned and will be filled as the company scales — with several seats reserved to be elected only after specific triggers (first outside capital, first independent audit).
9
Board seats
authorized in charter
2
Seated today
both founders
5
Independent seats planned
to be elected
2
Investor seats planned
activate post-funding
Directors
The 9.
Maria R. Lahti, MD
Two-year term, renewable. Recused from clinical-IP licensing votes.
Lead Independent Director
Will chair the Patient Safety committee. Founders are recruiting through the Board nominating process. Target seating: pre-Series Seed.
Audit Committee chair
Big-4 audit-partner experience preferred. Activates with the first outside-capital event or first external audit.
Compliance Committee chair
Healthcare-regulatory background; AG or HHS OCR experience preferred.
Patient-advocacy seat
Practicing clinician with patient-advocacy track record. Reserved seat — cannot be filled by a financial-services nominee.
Technology & risk seat
Distributed-systems or security-research background. Will sit on the Audit and Compliance committees.
Future investor designee #1
Observer-only on Audit. Seat materializes only if and when the company sells preferred stock.
Future investor designee #2
Observer-only on Compensation. Seat materializes only with a second preferred-round close.
Standing committees.
| Committee | Chair | Members | Charter |
|---|---|---|---|
| Audit | open | 3 independents (planned) | Annual + interim audit oversight; coordinates with external auditors |
| Compensation | open | 3 independents (planned) | Officer comp; MEPU vesting verification |
| Compliance | open | 3 independents + General Counsel observer (planned) | HIPAA/HITECH/state AG matters; reversal-policy oversight |
| Patient Safety | open | 3 independents + CMO observer (planned) | Clinical safety incidents, Provider AI hallucination rate, axis-evidence rigor |
| Nominating & Governance | open | 2 independents + Chair (planned) | Director nominations; charter amendments |